Immunodeficiency-associated lymphoproliferative disorders

Modern Pathology

Volumn 12, Issue 2, 1999, Pages 200-217

  Knowles, Daniel M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

AIDS lymphoma; Immune deficiency; Multiple myeloma; Non Hodgkin's lymphoma; Transplantation lymphoma

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; ARTICLE; CLONAL ANERGY; EPSTEIN BARR VIRUS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

HUMANS; IMMUNOSUPPRESSION; LYMPHOMA, AIDS-RELATED; LYMPHOPROLIFERATIVE DISORDERS;

EID: 0032957847     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Penn I, Hammon W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969;1:106-12.
2. Gatti RA, Good RA. Occurrence of malignancy in immunodeficiency diseases: a literature review. Cancer 1971;28:89-98.
3. Louie S, Daoust PR, Schwartz RS. Immunodeficiency and the pathogenesis of non-Hodgkin's lymphoma. Semin Oncol 1980;7:267-84.
4. Elenitoba-Johnson KSJ, Jaffe ES. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 1997;14:35-47.
5. Chadburn A, Cesarman E, Knowles DM. Molecular pathology of the post-transplantation lymphoproliferative disorders. Semin Diagn Pathol 1997;14:15-26.
6. Knowles DM. The molecular pathology of AIDS-related non-Hodgkin's lymphoma. Semin Diagn Pathol 1997;14:67-82.
7. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies: Part I. N Engl J Med 1984;311:235-42.
8. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies: Part II. N Engl J Med 1984;311:300-10.
9. Rosen FS, Wedgwood RJ, Eibl M. Primary immunodeficiency diseases: report of a World Health Organization Scientific Group. Immunodefic Rev 1992;3:195-236.
10. WHO Scientific Group. Primary immunodeficiency diseases. Clin Exp Immunol 1995;Suppl 1:1-24.
11. Filipovich AH, Shapiro R, Robison L, et al. Lymphoproliferative disorders associated with immunodeficiency. In: Magrath IT, editor. The non-Hodgkin's lymphomas. London: Edward Arnold; 1990. p. 135-54.
12. Frizzera G. Atypical lymphoproliferative disorders. In: Knowles DM, editor. Neoplastic hematopathology. Baltimore: Williams & Wilkins; 1992. p. 459-95.
13. Morrell D, Cromartie E, Swift M. Mortality and cancer incidence in 263 patients with ataxia telangiectasia. J Natl Cancer Inst 1986;77:89-92.
14. Perry GS, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J Pediatr 1980;97:72-8.
15. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 1987;7:294-9.
16. Penn I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 1978;83:492-502.
17. Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984;i:583-7.
18. Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981;41:4262-79.
19. Cleary ML, Warnke R, Sklar J. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients: clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med 1984;310:477-82.
20. Cleary ML, Nalesnik MA, Shearer WT, Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988;72:349-52.
21. Cleary ML, Sklar J. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 1984;ii:489-93.
22. Shearer WT, Ritz J, Finegold MJ, Guerra IC, Rosenblatt HM, Lewis DE, et al. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N Engl J Med 1985;312:1151-9.
23. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988;133:173-92.
24. Locker J, Nalesnik M. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 1989; 135:977-87.
25. Gaidano G, Dalla-Favera R. Proto-oncogenes and tumor suppressor genes. In: Knowles DM, editor. Neoplastic hematopathology, Baltimore: Williams & Wilkins; 1992. p. 245-62.
26. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplantation lymphoproliferative disorders. Blood 1995; 85:552-65.
27. Chadburn A, Chen JM, Hsu DT, Frizzera G, Cesarman E, Garrett TJ, et al. The morphologic and molecular genetic classification of post-transplantation lymphoproliferative disorders (PT-LPDs) has clinical relevance. Cancer. In press.
28. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-35.
29. Harris NE, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
30. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, et al. bcl-6 protein is expressed in germinal center B cells. Blood 1995;86:45-53.
31. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, et al. The bcl-6 proto-oncogene controls germinal center formation and Th2-type inflammation. Nat Genet 1997;16:161-70.
32. Lo Coco F, Ye BH, Lista F, Corradini P, Offit K, Knowles DM, et al. Rearrangements of the bcl-6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 1994;83:1757-9.
33. Migliazza A, Martinotti S, Chen W, Fusco C, Ye BH, Knowles DM, et al. Frequent somatic hypermutation of the 5′ non-coding region of the bcl-6 gene in B-cell lymphoma. Proc Natl Acad Sci USA 1995;92:12520-4.
34. Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowles DM. bcl-6 gene mutations in post-transplantation lymphoproliferative disorders (PT-LPDs) as predictors of response to therapy and clinical outcome. Blood 1998;92:2294-302.
35. Chadburn A, Cesarman E, Liu YF, Addonizio L, Hsu D, Michler RE, et al. Molecular genetic analysis demonstrates that multiple post-transplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms. Cancer 1995;75:2747-56.
36. Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM. Post-transplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 1995;85:1396-403.
37. Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, et al. Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med 1992;327:1710-4.
38. Lager DJ, Burgart LJ, Slagel DD. Epstein-Barr virus detection in sequential biopsies from patients with a post-transplantation lymphoproliferative disorder. Mod Pathol 1993;6:42-7.
39. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, et al. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990;64:4084-92.
40. Kyaw MT, Hurren L, Evans L, Moss DJ, Cooper DA, Benson E, et al. Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res Hum Retroviruses 1992;8:1869-74.
41. Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, et al. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin's lymphoma. Blood 1991;78:3004-11.
42. Scheinfeld AG, Nador RG, Cesarman E, Chadburn A, Knowles DM. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders. Am J Pathol 1997;151:805-12.
43. Fennewald S, van Santen V, Kieff E. Nucleotide sequence of a mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J Virol 1984;51:411-9.
44. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1995;43:831-40.
45. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP-1) from Chinese nasopharyngeal carcinoma. J Gen Virol 1991;72:2399-409.
46. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, et al. Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993;82:2937-42.
47. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996;88:242-51.
48. Kamel OW. Iatrogenic lymphoproliferative disorders in non-transplantation settings. Semin Diagn Pathol 1997;14:27-34.
49. Kamel OW, van de Rijn M, Weiss LM, Del Zoppo GJ, Hench PK, Robbins BA, et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 1993;328:1317-21.
50. Thomason RW, Craig FE, Banks PM, Sears DL, Myerson GE, Gulley ML. Epstein-Barr virus and lymphoproliferation in methotrexate-treated rheumatoid arthritis. Mod Pathol 1996;9:261-6.
51. Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996;14:1943-9.
52. Kamel OW, Weiss LM, van de Rijn M, Colby TV, Kingma DW, Jaffe ES. Hodgkin's disease in patients receiving long-term, low-dose methotrexate therapy. Am J Surg Pathol 1996;20: 1279-87.
53. Kamel OW, van de Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994;25:638-43.
54. Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet 1991;337:805-9.
55. Knowles DM, Chadburn A. Lymphadenopathy and the lymphoid neoplasms associated with the acquired immune deficiency syndrome (AIDS). In: Knowles DM, editor. Neoplastic hematopathology. Baltimore: Williams & Wilkins; 1992. p. 773-836.
56. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987;36(Suppl):1S-5S.
57. Levine AM. Non-Hodgkin's lymphomas and other malignancies in the acquired immunodeficiency syndrome. Semin Oncol 1987;14(Suppl 3):34-9.
58. Knowles DM, Chamulak GA, Subar M, Burke JS, Dugan M, Wernz J, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): the New York University experience. Ann Intern Med 1988;108:744-53.
59. Biggar RJ, Rabkin CS. The epidemiology of acquired immunodeficiency syndrome-related lymphomas. Curr Opin Oncol 1992;4:883-93.
60. Knowles DM. Pathology and pathogenesis of non-Hodgkin's lymphomas associated with HIV infection. In: Magrath I, editor. The non-Hodgkin's lymphomas, 2nd ed. New York; Oxford University Press; 1997. p. 471-94.
61. Levine AM. Acquired immunodeficiency syndrome-related lymphomas. Blood 1992;80:8-20.
62. Goldstein JD, Dickson DW, Moser FG, et al. Primary central nervous system lymphoma in acquired immunodeficiency syndrome: a clinical and pathologic study with results of treatment with radiation. Cancer 1991;67:2756-65.
63. MacMahon EME, Glass JD, Hayward SD, Mann RB, Becker PS, Charache J, et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991;338:969-73.
64. Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 1989;73:792-9.
65. Roithman R, Tourani JM, Andrieu JM. AIDS-associated non-Hodgkin's lymphoma. Lancet 1991;338:884-5.
66. Raphael J, Gentilhomme O, Tulliez M, Byron PA, Diebold J. Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1991;115:15-20.
67. Levine AM, Sullivan-Halley J, Pike MC, Rarick MU, Loureiro C, Bernstein-Singer M, et al. HIV-related lymphoma: prognostic factors predictive of survival. Cancer 1991;68:2466-72.
68. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said J, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpesvirus. Blood 1996;88:645-56.
69. Raphael MM, Audouin J, Lamine M, Delecluse HJ, Vuillaume M, Lenoir GM, et al. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma: correlation with histologic features in 36 cases. Am J Clin Pathol 1994;101:773-82.
70. Pelicci PG, Knowles DM Jr, Arlin ZA, Wieczorek R, Luciw P, Dina D, et al. Multiple monoclonal B-cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders: implications for lymphomagenesis. J Exp Med 1986;164: 2049-60.
71. Subar M, Neri A, Inghirami G, Knowles DM, Dalla-Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988;72:667-71.
72. Ballerini P, Gaidano G, Gong JZ, Tassi V, Saglio G, Knowles DM, et al. Multiple genetic lesions in AIDS-related non-Hodgkin's lymphoma. Blood 1993;81:166-76.
73. McGrath MS, Shiramizu B, Meeker TC, Kaplan LD, Herndier B. AIDS-associated polyclonal lymphoma: identification of a new HIV-associated disease process. J Acquir Immune Defic Syndr 1991;4:408-15.
74. Meeker TC, Shiramizu B, Kaplan L, Herndier B, Sanchez H, Grimaldi JC, et al. Evidence for molecular subtypes of HIV-associated lymphoma: division into peripheral monoclonal, polyclonal, and central nervous system lymphoma. AIDS 1991;5:669-74.
75. Shiramizu B, Herndier B, Meeker TC, Kaplan L, McGrath M. Molecular and immunophenotypic characterization of AIDS-associated Epstein-Barr virus-negative polyclonal lymphoma. J Clin Oncol 1992;10:383-9.
76. Nador RG, Chadburn A, Cesarman E, et al. Correlative morphologic and molecular genetic analysis of 74 AIDS-related systemic non-Hodgkin lymphomas.
77. Seiden M, Sklar J. AIDS and non-Hodgkin's lymphoma: a pre-pre-B-cell monoclonal lymphoma versus a novel mechanism of polyclonality. J Clin Oncol 1992;10:1650-1.
78. Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW, Knowles DM. AIDS-related polymorphic lymphoproliferative disorders.
79. Inghirami G, Grignani F, Sternas L, Lombardi L, Knowles DM, Dalla-Favera R. Down-regulation of EFA-1 adhesion receptors by c-myc oncogene in human B-lymphoblastoid cells. Science 1990;250:682-95.
80. Clayberger C, Wright A, Medeiros EJ, Koller TD, Link MP, Smith SD, et al. Absence of cell surface EFA-1 as a mechanism of escape from immunosurveillance. Lancet 1987;2:533-6.
81. Inghirami G, Wieczorek R, Zhu BY, Silber R, Dalla-Favera R, Knowles DM, et al. Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. Blood 1988;72:1431-4.
82. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Kaposi's sarcoma-associated DNA sequences of nonhuman origin: evidence for a new human herpes virus. Science 1994;266:1865-9.
83. Cesarman E, Knowles DM. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV 8): a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Semin Diagn Pathol 1997;14:54-66.
84. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
85. Cesarman E, Nador RG, Aozasa K, Delsol G, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus in non-AIDS-related lymphomas occurring in body cavities. Am J Pathol 1996;149:53-7.
86. Iuchi K, Aozasa K, Yamamoto S, Mori T, Tajima K, Minato K, et al. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax: summary of clinical and pathological findings in 37 cases. Jpn J Clin Oncol 1989;19:249-57.
87. Fukayama M, Ibuka T, Hayashi Y, Ooba T, Koike M, Mizutani S. Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol 1993;143:1044-9.
88. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus (KSHV/ HHV 8) contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 1996;70:8218-23.
89. Levine AM. HIV-associated Hodgkin's disease. Hematol Oncol Clin North Am 1996;10:1135-48.
90. Andrieu JM, Roithmann S, Tourani JM, Levy R, Desablens B, le Maignan C, et al. Hodgkin's disease during HIV1 infection: the French Registry experience. Ann Oncol 1993;4:635-41.
91. Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E, et al. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and tumors. J Clin Oncol 1995;13:1758-67.
92. Chadburn A, Cesarman E, Jagirdar J, Subar M, Mir RN, Knowles DM. CD30(Ki-1) positive anaplastic large-cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 1993;72:3078-90.